Ethical Issues in International Biomedical Research: A Casebook

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $31.45
Usually ships in 1-2 business days
(Save 40%)
Other sellers (Hardcover)
  • All (7) from $31.45   
  • New (2) from $43.31   
  • Used (5) from $31.45   

Overview

Ethical Issues in International Biomedical Research is the definitive book on the ethics of research involving human subjects in developing countries. Using 21 actual case studies, it covers the most controversial topics, including the ethics of placebo research in Africa, what benefits should be provided to the community after completion of a research trial, how to address conflicts between IRBs in developed and developing countries, and undue inducement of poor people in developing countries. Each case is accompanied by two expert commentaries, written by many of the worlds leading experts in bioethics as well as new voices with research experience in developing countries. No other volume has this scope. Students in bioethics, public and international health, and ethics will find this book particularly useful.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Ana Smith Iltis, PhD (Saint Louis University)
Description: This book introduces and discusses a range of ethical issues that emerge in conducting international biomedical research from the perspective of researchers and scholars from around the world.
Purpose: It aims to broaden the literature on international research ethics. Through cases and commentaries, the book raises awareness of ethical issues that emerge in the conduct of international biomedical research and successfully presents competing views on how to evaluate and resolve these issues.
Audience: The book is intended for persons engaged in international research as well as for those working in research ethics, including bioethicists, lawyers, and policy makers. The use of cases, the range of issues addressed, and the perspectives included will capture the interests of these different groups and deepen their understanding of international research ethics.
Features: Each of the book's eight parts addresses a condition for the ethical conduct of international research. Each part includes one or more cases that illustrate the ethical issues in context and case commentaries. The use of cases to illustrate the types of ethical issues that arise will enable persons familiar with international research to identify comparable issues in their own areas. For those unfamiliar with international biomedical research, the cases provide a context for situating theoretical concerns in practice. The commentaries, written by authors from developing and developed nations, introduce readers to a range of concerns and possible solutions. Educators and workshop facilitators will find the cases helpful for classroom use.
Assessment: This is a well written book and a must-read for anyone trying to understand the concerns associated with international biomedical research. The cases address research in many parts of the world on different disorders and conditions. The commentaries give readers a better appreciation of the breadth and depth of the relevant ethical issues.
Read More Show Less

Product Details

  • ISBN-13: 9780195179224
  • Publisher: Oxford University Press, USA
  • Publication date: 2/15/2007
  • Edition description: New Edition
  • Pages: 400
  • Product dimensions: 9.30 (w) x 6.40 (h) x 1.00 (d)

Meet the Author

St. Michael's Hospital and University of Toronto

National Institutes of Health

Yale University Medical School

all at the Department of Clinical Bioethics

Read More Show Less

Table of Contents

Contributors     xix
Introduction   James V. Lavery   Christine Grady   Elizabeth R. Wahl   Ezekiel J. Emanuel     3
Collaborative Partnership
Community Involvement in Biodiversity Prospecting in Mexico     21
Private and Public Knowledge in the Debate on Bioprospecting: Implications for Local Communities and Prior Informed Consent   Brent Berlin   Elois A. Berlin     26
Politics, Risk, and Community in the Maya ICBG Case   Fern Brunger   Charles Weijer     35
Selling Genes     43
What Might Tonga Learn from Iceland?   James Till   David L. Tritchler     46
Whose DNA? Tonga and Iceland, Biotech, Ownership, and Consent   Lopeti Senituli   Margaret Boyes     53
Sustainability of a Fluoride Varnish Feasibility Study in Nicaragua     64
Sustainability and Obligations to the Community in the Nicaragua Floride Varnish Pilot Study: The Investigator's Perspective   Martin Hobdell     67
Assessing the Sustainability of the Nicaragua Fluoride Varnish Study   Florencia Luna     71
Social Value
Malarone Testing in Pregnant Women in Thailand     79
Proposed Phase 3 Trials of Malarone in Pregnancy Are Unethical   Juntra Karbwang     82
A Phase 3 Trial of Malarone in Pregnancy as a Pubic Good   Janis Lazdins     84
Neglected Diseases: Incentives to Conduct Research in Developing Countries     87
Drug Development for Visceral Leishmaniasis: A Failure of the Market and Public Policy   James Orbinski   Solomon Benatar     90
Bringing Innovations for Diseases of Poverty to Market: The Case of Paromomycin for Visceral Leishmaniasis   Hannah Kettler     97
Scientific Validity
Evaluating Home-Based Treatment Strategies for Neonatal Sepsis in India     105
Did the SEARCH Neonatal Sepsis Trial Violate the Declaration of Helsinki?   Zulfiqar A. Bhutta     109
The SEARCH Neonatal Sepsis Study: Was It Ethical?   Marcia Angell     114
The Limitations of Knowledge     116
The Challenge of Clinical Equipoise in the Tigray Malaria Intervention Trial   James V. Lavery     119
Could the Investigators Foresee the Outcome of the Tigray Trial?   Jerome Singh     126
Controversy surrounding the Scientific Value of the VaxGen/Aventis (RV144) Phase 3 Vaccine Trial in Thailand     131
A Sound Rationale Needed for Phase 3 HIV-1 Vaccine Trials   Dennis R. Burton   Ronald C. Desrosiers   Robert W. Doms   Mark B. Feinberg   Robert C. Gallo    Beatrice Hahn   James A. Hoxie   Eric Hunter   Bette Korber   Alan Landay   Michael M. Lederman   Judy Lieberman   Joseph M. McCune   John P. Moore   Neal Nathanson   Louis Picker   Douglas Richman   Charles Rinaldo   Mario Stevenson   David I. Watkins   Steven M. Wolinsky   Jerome A. Zack     135
HIV Vaccine Trial Justified   John G. McNeil   Margaret I. Johnston   Deborah L. Birx   Edmund C. Tramont     137
Thailand's Prime-Boost HIV Vaccine Phase III   Charal Trinvuthipong     139
Support for the RV144 HIV Vaccine Trial   Robert Belshe   Genoveffa Franchini   Marc P. Girard   Frances Gotch   Pontiano Kaleebu   Marta L. Marthas   Michael B. McChesney   Rose McCullough   Fred Mhalu   Dominique Salmon-Ceron   Rafick-Pierre Sekaly   Koen van Rompay   Bernard Verrier   Britta Wahren   Mercedes Weissenbacher     141
Support for the RV144 HIV Vaccine Trial (2)   Maureen Baehr   Dana Cappiello   Chris Collins   David Gold   Pontiano Kaleebu   Alexandre Menezes   Mike Powell   Robert Reinhard   Luis Santiago   Bill Snow   Jim Thomas   Steve Wakefield$dstaff: Mitchell Warren$dEd Lee$dHuntly Collins     142
Response from Burton et al.   Dennis R. Burton   Ronald C. Desrosiers   Robert W. Doms   Mark B. Feinberg   Beatrice H. Hahn   James A. Hoxie   Eric Hunter   Bette T. M. Korber   Alan L. Landay   Michael M. Lederman   Judy Lieberman   Joseph M. McCune   John P. Moore   Neal Nathanson   Louis Picker   Douglas D. Richman   Charles R. Rinaldo   Mario Stevenson   David I. Watkins   Steven M. Wolinsky   Jerome A. Zack     143
Response from Gallo   Robert C. Gallo     144
Outstanding Questions on HIV Vaccine Trial   Richard Jefferys   Mark Harrington     145
Response to Jefferys and Harrington   John G. McNeil   Margaret I. Johnston   Edmund C. Tramont   Deborah L. Birx     146
Fair Subject and Community Selection
Pharmaceutical Research in Developing Countries     151
Benefit to Trial Participants or Benefit to the Community? How Far Should the Surfaxin Trial Investigators' and Sponsors' Obligations Extend?   Robert J. Temple     155
The Developing World as the "Answer" to the Dreams of Pharmaceutical Companies: The Surfaxin Story   Peter Lurie   Sidney M. Wolfe     159
Trading Genes for Toothbrushes     171
Ethics and Research on Human Genetic Material   Simona Giordano   John Harris     174
Should the Aka Pygmy People Be Targeted for Genetic Research?   Mohammed G. Kiddugavu     180
Testing a Phase 1 Malaria Vaccine     184
The Paradox of Exploitation: The Poor Exploiting the Rich   Ezekiel J. Emanuel     189
Reverse Exploitation in the Baltimore Malaria Vaccine Study   Bernard Dickens     195
Favorable Risk-Benefit Ratio
Ethical Complications during an Investigation of Malaria Infection in Native Amazonian Populations in Western Brazil     203
Treating Asymptomatic Malaria Carriers in an Epidemiological Study in Rondonia, Brazil: The Investigator's Perspective   Fabiana Alves     207
Treatment of Symptomatic and Asymptomatic Malaria Carriers in a Study of Native Amazonian Populations in Western Brazil: Is There a Favorable Risk-Benefit Ratio?   Ambrose Otau Talisuna     212
Access to Treatment for Trial Participants Who Become Infected with HIV during the Course of Phase 1 Trials of a Preventive HIV Vaccine in South Africa     217
The Limits of Obligations to Provide Treatment in the South African Phase I HIV Vaccine Trials   Catherine Slack   Melissa Stobie   Nicola Barsdorf     219
Shared Responsibilities for Treatment in the South African Phase 1 HIV Preventive Vaccine Trials   Christine Grady   Robert J. Levine     225
Independent Review
How Independent Is Independent Review?     233
Context, Dual Obligations, and the Vulnerability of Independent Review   Donna Knapp van Bogaert   Godfrey Tangwa     237
Research Ethics in South Africa: Putting the Mpumalanga Case into Context   Peter Cleaton-Jones     240
Which Regulations Offer Subjects the Best Protection?     246
Ensuring Consent Forms Do Not Breach the Confidentiality of Trial Participants   Ron Gray     250
Balancing Requirements of Confidentiality and Sponsorship Transparency in the Rakai Circumcision Trial   Mary Ann Luzar   Linda Ehler     255
Informed Consent
The Challenge of Informed Consent in a Genetic Epidemiology Study of Noma in Rural Nigeria     263
Local Culture and Informed Consent in the Noma Study   Patricia Marshall     267
Refocusing the Ethics of Informed Consent: Could Ritual Improve the Ethics of the Noma Study?   James V. Lavery     272
Compensation for Families Who Consent to Research Autopsy for Their Children in a Study of Malaria Mortality in Malawi     281
What It Means to Offer an Autopsy in Malawi   Kondwani Kayira   Lloyd Bwanaisa   Alfred Njobvu   Grace Malenga   Terrie Taylor     285
Culturally Sensitive Compensation in Clinical Research   Trudo Lemmens   Remigius Nwabueze     287
Respect for Enrolled Subjects and Study Communities
A Randomized Trial of Low-Phytate Corn for Maternal-Infant Micronutrient Deficiency in Rural Guatemala     297
The Guatemala Low-Phytate Corn Trial: The Investigators' Assessment   Michael Hambidge   Manolo Mazariegos   Noel W. Solomons     300
A Community Welfare Perspective on the Ethics of the Guatemala Low-Phytate Corn Trial   Eric M. Meslin   Godwin Ndossi     305
Obligations to Participants Harmed in the Course of the N-9 Multicenter Vaginal Microbicide Trial in South Africa     311
Ethical Challenges in the N-9 Trial: The Investigator's Perspective   Gita Ramjee     314
Was the N-9 Trial Ethical? Questions and Lessons   Douglas Wassenaar   Carel IJsselmuiden     319
What Are the Investigators' Responsibilities to HIV-Positive Women Who Were Screened Out of the N-9 Trial?   Leah Belsky   Christine Pace     325
Ethical Challenges and Controversy in a Retrospective Study of HIV-1 Transmission in Uganda     330
Obligations to Research Subjects in the Rakai HIV Transmission Study: The Investigator's Perspective   Thomas C. Quinn     333
Researchers' Obligations to Uninfected Partners in Discordant Couples in an HIV-1 Transmission Trial in the Rakai District, Uganda   Dirceu Greco     340
Protecting Subjects in a Study of Domestic Violence in South Africa     347
Generating Needed Evidence while Protecting Women Research Participants in a Study of Domestic Violence in South Africa: A Fine Balance   Rachel Jewkes   Jennifer Wagman     350
Minimizing the Risk to Women in a Study of Domestic Violence in South Africa: Easier Said Than Done   Angela Wasunna     355
Economic, Social, Health, and Development Indicators for the Case Countries     360
Index     363
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)